Skyrizi® (risankizumab-rzaa)

Skyrizi® (risankizumab) is a prescription medication that is FDA-approved to treat moderate and severe plaque psoriasis in adults. Skyrizi is also approved to treat psoriatic arthritis in adults, and it is given by injection under the skin at weeks 0 and 4, then after every 12 weeks.

In clinical trials, 3 out of 4 patients who used Skyrizi® achieved 90% clearer skin after only 2 doses of this medication.

If your condition is not improving with other treatment options, and you think you would benefit from Skyrizi® (risankizumab), talk to your Tono dermatologist about this medication.

Want to receive treatment from expert doctors? See if we operate in your state.